This story originally ran on Oct. 21.
German antibody firm Morphosys announced this week a collaboration with Japanese pharma Daiichi Sankyo for the development of therapeutic antibodies against hospital-acquired infections.
Daiichi Sankyo becomes Morphosys's first collaborator using Morphosys' HuCAL Platinum antibody library for new drug discovery in infectious diseases.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
